Back to search

University of Leeds

The use of machine learning/deep learning in PET/CT interpretation to aid in outcome prediction in lymphoma

Abstract

dc:description.abstract

Lymphoma is a haematopoietic malignancy consisting of two broad categories: Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). These categories can be further split into subtypes with classical HL (cHL) and diffuse large B cell lymphoma (DLBCL) being the commonest subtypes. The gold standard imaging modality for staging and response assessment for cHL and DLBCL is 2-deoxy-2-[fluorine-18]fluoro-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT), with patients having a worse prognosis if they do not demonstrate complete metabolic response (CMR). However, approximately 15% of patients will relapse even after CMR. Therefore, being able to identify patients who are likely to relapse it may be possible to stratify treatment early to improve patient outcomes. The aim of this project is to develop and test image derived predictive models based on the baseline PET/CT to risk stratify patients pre-treatment.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Frood, Russell Thomas
Advisors dc:contributor.advisor
  • Scarsbrook, Andrew
  • Frangi, Alejandro
  • Tsoumpas, Charalampos
  • Gleeson, Fergus
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.878035

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Frood, Russell Thomas. The use of machine learning/deep learning in PET/CT interpretation to aid in outcome prediction in lymphoma. doctoral thesis, University of Leeds, 2022.